🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chronic kidney disease (CKD), is characterized by accelerated development o...
Status
Completed
Location
Poznan University of Medical Sciences
Start Date
2016-03-25
Trial ID
NCT05214872
Treatments Being Tested
This phase II trial tests whether 68Ga-FAPI-46 positron emission tomography...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2022-11-15
Trial ID
NCT05518903
Treatments Being Tested
Bladder cancer is a highly heterogeneous malignancy characterized by freque...
Status
Recruiting
Location
The Second Hospital of Lanzhou University
Start Date
2026-02-25
Trial ID
NCT07424560
Treatments Being Tested
The pathophysiology of systemic sclerosis (SSc) is still poorly understood ...
Status
Recruiting
Location
Hop Claude Huriez Chu Lille
Start Date
2022-06-08
Trial ID
NCT05273138
Treatments Being Tested
Individuals with suspected primary immunodeficiency will be studied and the...
Status
Recruiting
Location
Division of Immunology
Start Date
2016-02
Trial ID
NCT02735824
Treatments Being Tested
This phase II trial studies the effect of rogaratinib in treating patients ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-05-03
Trial ID
NCT04595747
RATIONALE: Studying samples of tumor tissue and blood from patients with ca...
Status
Completed
Location
Fox Chase Cancer Center - Philadelphia
Start Date
2007-08
Trial ID
NCT00900016
This feasibility trial studies the use of gallium-68 (68Ga)-FAPI as the ima...
Status
Withdrawn
Location
Stanford University Hospitals and Clinics
Start Date
2023-07
Trial ID
NCT04023240
Treatments Being Tested
Positron Emission Tomography (PET) provides a valuable tool for the diagnos...
Status
Unknown
Location
China, Hubei Province
Start Date
2020-07-01
Trial ID
NCT04605939
RATIONALE: Growth factors, such as palifermin, may prevent chronic graft-ve...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2010-09
Trial ID
NCT01233921
Treatments Being Tested